Surrozen, Inc.

SRZN·NasdaqCM
Compare
24.76−4.93 (−16.60%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours24.14−0.62 (−2.50%)Oct 12, 6:55 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close29.69
Open28.70
Day range22.9429.90
52-week range11.3937.83
Off day high−17.19%
Off 52-week high−34.55%
Volume1.53M
Avg. volume (3M)493.16K
Market cap291.02M
EPS (TTM)-39.08
Forward P/E-5.91
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding11.75M
Short interest—
Earnings dateMay 9, 2025
Analyst target—
Profit margin—

Against its peers

Compare in full ›
SRZN EYPT IRD OCGN NBP KOD
Market cap 291.02M 278.35M 386.03M 321.21M 153.12M 6.24B
P/E (TTM) — — — — — —
Forward P/E -5.9 -1.2 -6.5 -3.7 -1.2 -28.9
Price/book -1.3 1.7 -29.6 -19.3 0.8 101.9
Dividend yield — — — — — —
1-year change +114.83% −74.51% +132.50% −40.25% −75.91% +760.95%
Today −16.60% −2.35% −0.22% −0.87% −5.38% −0.61%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Surrozen's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
EyePoint, Inc.EYPT · Biotechnology 278.35M 3.3200 −2.35%
Opus Genetics, Inc.IRD · Biotechnology 386.03M 4.6400 −0.22%
Ocugen, Inc.OCGN · Biotechnology 321.21M 0.9472 −0.87%
NovaBridge BiosciencesNBP · Biotechnology 153.12M 1.3200 −5.38%
Kodiak Sciences Inc.KOD · Biotechnology 6.24B 99.26 −0.61%
YD Bio LtdYDES · Biotechnology 448.36M 6.33 −5.94%
4D Molecular Therapeutics, Inc.FDMT · Biotechnology 718.17M 13.00 −2.48%
Keros Therapeutics, Inc.KROS · Biotechnology 230.19M 11.61 −2.85%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
X4 Pharmaceuticals, Inc.XFOR · Boston, MA 279.59M 2.8200 −3.09%
Fulcrum Therapeutics, Inc.FULC · Cambridge, MA 286.43M 3.7500 −0.53%
Clinuvel Pharmaceuticals LimitedCUVL · Melbourne, VIC 281.92M 5.58 +0.43%
EyePoint, Inc.EYPT · Watertown, MA 278.35M 3.3200 −2.35%
Palisade Bio, Inc.PALI · Denver, CO 277.09M 1.5900 +3.25%
Abeona Therapeutics Inc.ABEO · Cleveland, OH 280.20M 4.9000 −0.81%
Prelude Therapeutics IncorporatedPRLD · Wilmington, DE 298.47M 3.7400 −3.86%
Larimar Therapeutics, Inc.LRMR · Bala Cynwyd, PA 262.82M 2.5300 −5.24%

Healthcare companies of a similar market value (291.25M).

Company Mkt cap Price Today
Perspective Therapeutics, Inc.CATX · Medical Devices 294.51M — —
Mobia Medical, Inc.MOBI · Medical Devices 286.30M 8.60 −0.35%
X4 Pharmaceuticals, Inc.XFOR · Biotechnology 279.59M 2.8200 −3.09%
Fulcrum Therapeutics, Inc.FULC · Biotechnology 286.43M 3.7500 −0.53%
Clinuvel Pharmaceuticals LimitedCUVL · Biotechnology 281.92M 5.58 +0.43%
EyePoint, Inc.EYPT · Biotechnology 278.35M 3.3200 −2.35%
Palisade Bio, Inc.PALI · Biotechnology 277.09M 1.5900 +3.25%
Abeona Therapeutics Inc.ABEO · Biotechnology 280.20M 4.9000 −0.81%

The stocks whose daily moves over the past year went most closely with Surrozen's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Abeona Therapeutics Inc.ABEO · Correlation 0.32 280.20M 4.9000 −0.81%
Bicycle Therapeutics plcBCYC · Correlation 0.31 265.97M 3.8000 −2.31%
Alumis Inc.ALMS · Correlation 0.30 913.81M 7.06 −1.40%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All SRZN news ›
Clinical Trials Arena·Positive

Surrozen secures FDA clearance for SZN-8141 clinical trial

Surrozen intends to dose the first patient in its DUET clinical trial during the fourth quarter of 2026. The US Food and Drug Administration (FDA) has cleared Surrozen’s investigational new drug (IND) application for SZN-8141 to begin…

Mugglehead·Positive

Surrozen gains FDA IND clearance for SZN-8141

Surrozen expects to dose DUET's first patient in Q4; clearance also meets a condition for a US$95.1M financing close around Oct. 20. A study of an experimental injection for diabetic macular edema can begin after Surrozen, Inc. NASDAQSRZN…

From articles in the 4Search news index.

In the news

4mentions in 30 days
4with it in the headline
Positivesentiment

Mentioned with

Eli Lilly4Astrazeneca3Lenz Therapeutics3Novo Nordisk3Sanofi3Therapeutics Inc.3U.S. Food and Drug Administration3Pfizer2

People in the coverage

Adrian Gottschalk3Craig Parker3Surrozen3Trung Huynh3Tzield3Yutrepia3

Themes

Clinical Trials3FDA3Health3Biotechnology2Brian Kilmeade2Clay Travis2Conservative Talk2Pharma2

Most coverage from

  1. clinicaltrialsarena.com1
  2. investingnews.com1
  3. mugglehead.com1
  4. themarketsdaily.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.